This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
David Slifka, Vice President, Commercial Enablement The digitalhealth ecosystem is a complex place. Confusion abounds among healthcare providers regarding digital therapeutics (DTx) terminology and classifications, and understandably so. DTx fall within the digital medicine subset within the larger digitalhealth ecosystem.
–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digitalhealth solutions to better meet the needs of healthcare professionals, regulators and patients. in 2060.
Insights powered by clinically responsible AI will give all parties involved in patient care a comprehensive guide on how to safely handle transitions to post-acute care. ACOs will turn to AI to better manage transitions of care when patients are at their most vulnerable. Today, it’s largely restricted to genomics and oncology.
In the PDf, you’ll find links on how to find your senators and representatives, and I encourage you to call and write to them to encourage them to vote on, and pass the Open Act. On DigitalHealth Today, I leverage my experiences to help great leaders and innovators tell their stories and connect to users, investors and other stakeholders.
In her role, she is responsible for finding use cases to apply digital solutions and services across the business and bring efficiencies that save time, lower costs and open up new business channels for Almirall. How to define and win buy-in of ‘Digital Transformation' within pharma companies. DigitalHealth Events.
About Seamless Therapeutics Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drugdevelopment.
The WHO and the India G20 presidency emphasised its importance by launching ‘The Global Initiative of DigitalHealth’ (GIDH) in August, proclaiming: “Digitalhealth is a proven accelerator to advance health outcomes and achieve Universal Health Coverage and health-related Sustainable Development Goals.”
It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. But how can healthcare organisations best leverage this technology? A framework called the "Taker-Shaper-Maker" model can be used to describe how organisations can adopt generative AI.
DTx could be used in phase II of clinical trials for monitoring patients, helping reduce costs of drugdevelopment and speeding up that phase. Healthcare professionals are a very important group to adopt DTx but education is essential for them to understand the benefits and how to use DTx. Find Out How! Aline Noizet.
Bardy Diagnostics is a digitalhealth and remote patient monitoring company focused on addressing a long-standing complaint by cardiac electrophysiologists and cardiologists regarding their frequent inability to clearly distinguish the P-wave on ECG strips of existing monitors. And the list will continue to be updated over time.
Deerfield invests across the life science, medical device, diagnostic, digitalhealth, and health service industries at every stage of evolution. The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drugdevelopment in oncology.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content